{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:27:44Z","timestamp":1788398864174,"version":"build-2803163510"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"The Center of Excellence in Clinical Virology","award":["GCE 58-014-30-004"],"award-info":[{"award-number":["GCE 58-014-30-004"]}]},{"name":"Research Chair Grant from NSTDA","award":["P-15-50004"],"award-info":[{"award-number":["P-15-50004"]}]},{"name":"Rachadapisek Sompote Fund of Chulalongkorn University for postdoctoral fellowships"},{"name":"Rachadapisek Sompote Fund of Chulalongkorn University for postdoctoral fellowships"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0202637","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T13:31:12Z","timestamp":1534771872000},"page":"e0202637","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Implementation of hepatitis B vaccine in high-risk young adults with waning immunity"],"prefix":"10.1371","volume":"13","author":[{"given":"Nawarat","family":"Posuwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnond","family":"Vorayingyong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vorapol","family":"Jaroonvanichkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujipat","family":"Wasitthankasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasamon","family":"Wanlapakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sompong","family":"Vongpunsawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-6807","authenticated-orcid":true,"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"ref1","unstructured":"WHO. Global hepatitis report. 2017. Available from: URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/255016\/1\/9789241565455-eng.pdf?ua=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/255016\/1\/9789241565455-eng.pdf?ua=1<\/ext-link>."},{"key":"ref2","unstructured":"WHO. Department of Communicable Diseases Surveillance and Response. Hepatitis B. 2002. Available from: URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/csr\/disease\/hepatitis\/HepatitisB_whocdscsrlyo2002_2.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/csr\/disease\/hepatitis\/HepatitisB_whocdscsrlyo2002_2.pdf<\/ext-link>."},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1365-3156.2006.01709.x","article-title":"Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization","volume":"11","author":"V Chongsrisawat","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/978-4-431-68255-4_137","article-title":"The Immunogenicity and Reactogenicity of Combined Tetravalent Diphtheria, Tetanus, Pertussis, and Hepatitis B Vaccine in Infants","author":"Y Poovorawan","year":"1994","journal-title":"Viral Hepatitis and Liver Disease"},{"issue":"3","key":"ref5","first-page":"496","article-title":"Experience of combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B vaccine in Thailand","volume":"28","author":"Y Poovorawan","year":"1997","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3\u20134","key":"ref6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(02)00461-9","article-title":"Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand","volume":"21","author":"S Chunsuttiwat","year":"2002","journal-title":"Vaccine"},{"issue":"44","key":"ref7","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1016\/j.vaccine.2009.08.034","article-title":"Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination","volume":"27","author":"P Tharmaphornpilas","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"e0150499","DOI":"10.1371\/journal.pone.0150499","article-title":"The Success of a Universal Hepatitis B Immunization Program as Part of Thailand&apos;s EPI after 22 Years&apos; Implementation","volume":"11","author":"N Posuwan","year":"2016","journal-title":"PLoS One"},{"issue":"RR-13","key":"ref9","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"40","year":"1991","journal-title":"MMWR Recomm Rep"},{"issue":"9203","key":"ref10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose","volume":"53","author":"E Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref12","first-page":"584","article-title":"Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17\u201318 November 2011","volume":"31","author":"D FitzSimons","year":"2013","journal-title":"Vaccine"},{"issue":"7\u20138","key":"ref13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0264-410X(00)00224-3","article-title":"Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory","volume":"19","author":"J Banatvala","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/INF.0000000000000994","article-title":"Markers of Protection in Children and Adolescents Six to Fourteen Years After Primary Hepatitis B Vaccination in Real Life: A Pilot Study","volume":"35","author":"I Brunskole Hummel","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1086\/599331","article-title":"Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers","volume":"200","author":"Y Poovorawan","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/hep.24442","article-title":"Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program","volume":"54","author":"BJ McMahon","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose","volume":"214","author":"MG Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"ref18","unstructured":"Center for Disease Control and Prevention. CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. 2013. Available from URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6210a1.htm\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6210a1.htm<\/ext-link>"},{"key":"ref19","unstructured":"Hepatitis B Foundation. History of hepatitis B vaccine. 2018. Available from URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hepb.org\/prevention-and-diagnosis\/vaccination\/history-of-hepatitis-b-vaccine\/\" xlink:type=\"simple\">http:\/\/www.hepb.org\/prevention-and-diagnosis\/vaccination\/history-of-hepatitis-b-vaccine\/<\/ext-link>"},{"issue":"22","key":"ref20","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.1989.03420220092033","article-title":"Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers","volume":"261","author":"Y Poovorawan","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"F47","DOI":"10.1136\/fn.77.1.F47","article-title":"Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers","volume":"77","author":"Y Poovorawan","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.vaccine.2008.01.028","article-title":"Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age","volume":"26","author":"Y Poovorawan","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/vim.2008.0087","article-title":"Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18\u201320 years after neonatal immunization","volume":"22","author":"T Chinchai","year":"2009","journal-title":"Viral Immunol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.vaccine.2009.10.074","article-title":"Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand","volume":"28","author":"Y Poovorawan","journal-title":"Vaccine"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2893.2010.01312.x","article-title":"Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region","volume":"18","author":"Y Poovorawan","year":"2011","journal-title":"J Viral Hepat"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4161\/hv.19989","article-title":"Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers","volume":"8","author":"Y Poovorawan","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4161\/hv.24844","article-title":"Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand","volume":"9","author":"Y Poovorawan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0030-4220(83)90363-8","article-title":"Hepatitis B vaccine\u2014what to expect","volume":"56","author":"CM Martin","year":"1983","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"9959","key":"ref29","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"C Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/clinids\/17.3.475","article-title":"A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates","volume":"17","author":"L Ding","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0022-3476(95)70398-5","article-title":"Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen","volume":"126","author":"PI Lee","year":"1995","journal-title":"J Pediatr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0202637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:44:25Z","timestamp":1540205065000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0202637"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0202637","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]}}}